PMID- 33887230 OWN - NLM STAT- MEDLINE DCOM- 20210924 LR - 20220802 IS - 1879-2650 (Electronic) IS - 0005-2728 (Print) IS - 0005-2728 (Linking) VI - 1862 IP - 8 DP - 2021 Aug 1 TI - Oxidative phosphorylation K(0.5)ADP in vitro depends on substrate oxidative capacity: Insights from a luciferase-based assay to evaluate ADP kinetic parameters. PG - 148430 LID - S0005-2728(21)00063-3 [pii] LID - 10.1016/j.bbabio.2021.148430 [doi] AB - The K(0.5)ADP of oxidative phosphorylation (OxPhos) identifies the cytosolic ADP concentration which elicits one-half the maximum OxPhos rate. This kinetic parameter is commonly measured to assess mitochondrial metabolic control sensitivity. Here we describe a luciferase-based assay to evaluate the ADP kinetic parameters of mitochondrial ATP production from OxPhos, adenylate kinase (AK), and creatine kinase (CK). The high sensitivity, reproducibility, and throughput of the microplate-based assay enabled a comprehensive kinetic assessment of all three pathways in mitochondria isolated from mouse liver, kidney, heart, and skeletal muscle. Carboxyatractyloside titrations were also performed with the assay to estimate the flux control strength of the adenine nucleotide translocase (ANT) over OxPhos in human skeletal muscle mitochondria. ANT flux control coefficients were 0.91 +/- 0.07, 0.83 +/- 0.06, and 0.51 +/- 0.07 at ADP concentrations of 6.25, 12.5, and 25 muM, respectively, an [ADP] range which spanned the K(0.5)ADP. The oxidative capacity of substrate combinations added to drive OxPhos was found to dramatically influence ADP kinetics in mitochondria from several tissues. In mouse skeletal muscle ten different substrate combinations elicited a 7-fold range of OxPhos V(max), which correlated positively (R(2) = 0.963) with K(0.5)ADP values ranging from 2.3 +/- 0.2 muM to 11.9 +/- 0.6 muM. We propose that substrate-enhanced capacity to generate the protonmotive force increases the OxPhos K(0.5)ADP because flux control at ANT increases, thus K(0.5)ADP rises toward the dissociation constant, K(d)ADP, of ADP-ANT binding. The findings are discussed in the context of top-down metabolic control analysis. CI - Copyright (c) 2021 Elsevier B.V. All rights reserved. FAU - Willis, Wayne AU - Willis W AD - Department of Medicine, Division of Endocrinology, University of Arizona, Tucson, AZ, United States; Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona, Tucson, AZ, United States. Electronic address: waynewillis@deptofmed.arizona.edu. FAU - Willis, Elizabeth AU - Willis E AD - College of Medicine, University of Kentucky, Lexington, KY, United States. FAU - Kuzmiak-Glancy, Sarah AU - Kuzmiak-Glancy S AD - Department of Kinesiology, University of Maryland, College Park, MD, United States. FAU - Kras, Katon AU - Kras K AD - Department of Medicine, Division of Endocrinology, University of Arizona, Tucson, AZ, United States. FAU - Hudgens, Jamie AU - Hudgens J AD - College of Pharmacy, Midwestern University, Glendale, AZ, United States. FAU - Barakati, Neusha AU - Barakati N AD - Department of Medicine, Division of Endocrinology, University of Arizona, Tucson, AZ, United States. FAU - Stern, Jennifer AU - Stern J AD - Department of Medicine, Division of Endocrinology, University of Arizona, Tucson, AZ, United States; Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona, Tucson, AZ, United States. FAU - Mandarino, Lawrence AU - Mandarino L AD - Department of Medicine, Division of Endocrinology, University of Arizona, Tucson, AZ, United States; Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona, Tucson, AZ, United States. LA - eng GR - R01 DK047936/DK/NIDDK NIH HHS/United States GR - R01 DK066483/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20210420 PL - Netherlands TA - Biochim Biophys Acta Bioenerg JT - Biochimica et biophysica acta. Bioenergetics JID - 101731706 RN - 61D2G4IYVH (Adenosine Diphosphate) RN - EC 1.13.12.- (Luciferases) SB - IM MH - Adenosine Diphosphate/*metabolism MH - Animals MH - Humans MH - Kidney/*metabolism MH - Kinetics MH - Luciferases/*metabolism MH - Mice MH - Mitochondria/*metabolism MH - Mitochondria, Liver/*metabolism MH - Muscle, Skeletal/*metabolism MH - *Oxidative Phosphorylation MH - Oxidative Stress MH - Oxygen Consumption PMC - PMC8725320 MID - NIHMS1701235 OTO - NOTNLM OT - Adenine nucleotide translocase OT - Metabolic control OT - Michaelis-Menten kinetics OT - Respiration COIS- Declaration of interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. EDAT- 2021/04/23 06:00 MHDA- 2021/09/25 06:00 PMCR- 2022/08/01 CRDT- 2021/04/22 20:11 PHST- 2020/12/21 00:00 [received] PHST- 2021/03/30 00:00 [revised] PHST- 2021/04/07 00:00 [accepted] PHST- 2021/04/23 06:00 [pubmed] PHST- 2021/09/25 06:00 [medline] PHST- 2021/04/22 20:11 [entrez] PHST- 2022/08/01 00:00 [pmc-release] AID - S0005-2728(21)00063-3 [pii] AID - 10.1016/j.bbabio.2021.148430 [doi] PST - ppublish SO - Biochim Biophys Acta Bioenerg. 2021 Aug 1;1862(8):148430. doi: 10.1016/j.bbabio.2021.148430. Epub 2021 Apr 20.